Identification of risk groups in hepatoblastoma — another step in optimising therapy
- 31 July 2000
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (11) , 1343-1346
- https://doi.org/10.1016/s0959-8049(00)00138-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Comparative genomic hybridization analysis of hepatoblastomasGenes, Chromosomes and Cancer, 2000
- Hepatic stem‐like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV‐1 and OV‐6Histopathology, 1997
- Loss of heterozygosity on chromosome 1 in human hepatoblastomaInternational Journal of Cancer, 1996
- Extramedullary Hematopoiesis and Intratumoral Production of Cytokines in Childhood HepatoblastomaPediatric Research, 1995
- Hepatoblastoma — a bit of a success story?European Journal Of Cancer, 1994
- Malignant hepatic tumours in children: incidence, clinical features and aetiologyPaediatric and Perinatal Epidemiology, 1990
- Hepatoblastoma: An immunohistochemical and ultrastructural studyHuman Pathology, 1987
- Primary hepatic tumors of childhoodHuman Pathology, 1983
- Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatomaCancer, 1982
- Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of pediatrics surgical section survey — 1974Journal of Pediatric Surgery, 1975